An act amending the act of December 14, 1992 (P.L.1116, No.145), entitled "An act providing minimum standards, terms and conditions for the licensing of persons who engage in wholesale distributions in interstate commerce of prescription drugs; and making a repeal," further providing for definitions and for license application.

This bill amends Pennsylvania's Wholesale Prescription Drug Distributors License Act to update definitions and application requirements for drug manufacturers. It clarifies the definition of a "virtual manufacturer" as a company that manufactures and distributes drugs without taking physical possession of the products within the state. The bill requires license applicants to disclose their FDA approval status or intent to submit an application within 12 months, while explicitly stating that FDA approval cannot be made a condition for licensure. These changes affect pharmaceutical companies operating in Pennsylvania and streamline the licensing process for manufacturers at various stages of FDA approval.